Peptide Therapy Foundations: Immune Regulation
Course Details
This course examines the peptides that shape immune function: the thymic peptides that help regulate the maturation and balance of the immune response, and the host-defense peptides that act at the front line of innate immunity. It is written for clinicians who want to understand how these agents influence immune signaling and where each one fits in practice.
The lessons center on the thymic family. Thymalin, Thymosin Alpha-1, Thymosin Beta-4, and Thymulin each act on different aspects of immune regulation, from T-cell maturation and modulation to tissue repair and anti-inflammatory signaling. LL-37, a cathelicidin host-defense peptide, rounds out the picture with its role in innate antimicrobial defense and immune crosstalk.
Each lesson follows the same clinical lens: what the agent is, how it works, what the evidence shows, and what a practitioner weighs before applying it. Together they map the immune-regulating peptides as a group so you can reason about any single agent in the context of the others.
SSRP FACULTY
William Seeds, MD
William Seeds, MD
William Seeds, MD
Before establishing the SSRP Institute, Dr. Seeds served as a board-certified orthopedic surgeon and sports medicine specialist for nearly three decades, including Chief of Surgery, Orthopedic Residency Site Director, and Director of The Ohio Bone & Joint Institute for University Hospitals.
His significant contributions to sports medicine have been recognized at the NFL Hall of Fame. He has consulted for athletes across all major sports leagues, including the NFL, NHL, MLB, NBA, and even the performers on “Dancing with the Stars.”
Through his research at the SSRP Institute, Dr. Seeds continues to explore the cellular pathways and mechanisms that positively impact disease and dysfunction in the body as well as optimize physical performance.
Thymulin
In-ProgressLesson Resources
Overview
Thymulin, also known as serum thymic factor zinc, is a nine amino acid thymic nanopeptide produced exclusively by thymic epithelial cells. First described in the 1970s, it sits at the intersection of immune regulation and neuroendocrine signaling, which is what makes it a useful peptide to understand within Cellular Medicine.
A defining feature is its zinc dependence. The peptide is biologically inactive on its own and requires an equimolar ratio of zinc to adopt its active conformation, a structure confirmed by NMR imaging. Without adequate zinc, it does not work. This dependence also helps explain thymic involution with aging, where overexpression of metallothioneins one through three sequesters zinc and reduces thymulin bioavailability.
Immunomodulation and anti-inflammatory mechanisms
Thymulin promotes intrathymic and extrathymic T cell differentiation, supports CD4 and CD8 maturation, and increases natural killer cell cytotoxic activity. It also carries anti-apoptotic activity, reducing caspase-3 and P53-driven cell death in lymphocytes.
Much of its anti-inflammatory signature traces to NF-kB inhibition. The peptide stabilizes IkB-alpha, reduces its phosphorylation, and inhibits the IKK complex, with downstream suppression of Toll-like receptor 4, MAPK, and PKC signaling. In preclinical models this corresponds to decreased IL-1 beta, IL-6, TNF-alpha, IL-17, and interferon gamma, while the anti-inflammatory effect of IL-10 is preserved.
Neuroendocrine crosstalk and study contexts
Thymulin acts as a hypophyseotropic peptide, interacting with the growth hormone, prolactin, ACTH, and gonadotropin axes, with partial serotonin and melatonin restoration reported in inflammatory states. Preclinical work spans type 1 diabetes, multiple sclerosis severity, sepsis and endotoxemia, and airway remodeling in asthma and cystic fibrosis models, several using nanoparticle or gene-therapy delivery to extend a short free-peptide half-life of about ten minutes.
It is not approved for human use. It is a research peptide sourced from compounding pharmacies, and most of the evidence base is animal and in vitro rather than human clinical data.
Key clinical points
- Thymulin is biologically inactive without zinc; equimolar zinc co-administration, often 15 to 30 mg elemental zinc daily, is essential.
- Reported actions include T cell differentiation, NK cell activity, and NF-kB-mediated cytokine suppression, documented mainly in preclinical models.
- Subcutaneous research protocols described start around 100 mcg, dosed in the evening to align with thymic secretion, with titration upward.
- Monitoring may include serum and RBC zinc, copper, CD4 and CD8 counts, CRP, ESR, and inflammatory cytokines such as IL-6, IL-1 beta, and TNF-alpha.
- Caution applies in active autoimmune flares, pregnancy, and uncorrected zinc deficiency, given the theoretical risk of immune over-activation.
Questions? Our Provider Care Team is here to help.
We'd love to help you determine the best next steps on your Cellular Medicine journey.
Continue your learning journey
VIEW ALLAging-Associated Decline of Phosphatidylcholine Synthesis is a Malleable Trigger of Natural Mitochondrial Aging
Dr. Seeds explores how age-related decline in phosphatidylcholine synthesis may contribute to mitochondrial aging and why that matters in Cellular Medicine. This discussion connects membrane integrity, mitochondrial function, methylation, and metabolic resilience, while highlighting how this pathway may be more modifiable than we once thought.
1. Managing shingles outbreaks in GLP-1 patient through peptides (0:40)
2. Peptide strategies in suspected ALS (15:56)
3. Improving durability in dementia treatment (25:08)
In this bonus episode from the MM15 Virtual Summit, Dr. Seeds addresses an important question around the use of GLP-1s for metabolic balancing in patients who do not need to lose weight. He shares his perspective on what may be considered microdosing, along with the clinical thought process he uses when determining appropriate dosing in these more nuanced cases.
Additional questions from the MM15 Virtual Summit can be found in our accompanying article here: [insert article link]
Access the full MM15 Course here: Mastermind 15 on Aesthetics
The Limits of Alternative Peptide Delivery
Dr. Seeds reviews oral, sublingual, and transdermal peptide delivery, and explains why subcutaneous injection remains the gold standard for most peptides. (Question Link)
A Deeper Look at the RAAS System
Dr. Seeds uses this Rabbit Holes episode to build on Journal Club Episode 87, revisiting the renin-angiotensin-aldosterone system and its broader role in cellular signaling. The discussion focuses on receptor balance, local tissue effects, and the mechanisms linking RAS disruption to inflammation, fibrosis, and mitochondrial stress.(Article Link)
The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation
Dr. Seeds unpacks how RAS receptor balance drives inflammation, fibrosis, mitochondrial dysfunction, and tissue remodeling, far beyond its classical role in blood pressure regulation. (Article Link)
1. SSRI tapering resistance, anxiety during weaning (0:40)
2. Progressive multifocal dystonia (13:27)
3. Complex type 2 diabetes case in a lean, athletic patient (28:32)